Adverum Biotechnologies Inc (ADVM)
5.75
-0.42
(-6.81%)
USD |
NASDAQ |
Nov 21, 16:00
5.77
+0.02
(+0.35%)
After-Hours: 20:00
Adverum Biotechnologies Market Cap: 119.61M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 119.61M |
| November 20, 2024 | 128.35M |
| November 19, 2024 | 130.02M |
| November 18, 2024 | 142.50M |
| November 15, 2024 | 142.71M |
| November 14, 2024 | 150.82M |
| November 13, 2024 | 157.27M |
| November 12, 2024 | 164.13M |
| November 11, 2024 | 161.43M |
| November 08, 2024 | 166.42M |
| November 07, 2024 | 164.34M |
| November 06, 2024 | 165.17M |
| November 05, 2024 | 160.60M |
| November 04, 2024 | 156.85M |
| November 01, 2024 | 154.15M |
| October 31, 2024 | 151.75M |
| October 30, 2024 | 163.91M |
| October 29, 2024 | 161.42M |
| October 28, 2024 | 164.74M |
| October 25, 2024 | 165.99M |
| October 24, 2024 | 168.07M |
| October 23, 2024 | 168.90M |
| October 22, 2024 | 169.32M |
| October 21, 2024 | 171.82M |
| October 18, 2024 | 176.39M |
| Date | Value |
|---|---|
| October 17, 2024 | 168.07M |
| October 16, 2024 | 170.78M |
| October 15, 2024 | 159.96M |
| October 14, 2024 | 160.79M |
| October 11, 2024 | 159.13M |
| October 10, 2024 | 154.76M |
| October 09, 2024 | 156.42M |
| October 08, 2024 | 158.29M |
| October 07, 2024 | 154.76M |
| October 04, 2024 | 156.63M |
| October 03, 2024 | 151.43M |
| October 02, 2024 | 141.86M |
| October 01, 2024 | 137.08M |
| September 30, 2024 | 146.02M |
| September 27, 2024 | 144.36M |
| September 26, 2024 | 137.49M |
| September 25, 2024 | 137.08M |
| September 24, 2024 | 144.36M |
| September 23, 2024 | 143.11M |
| September 20, 2024 | 155.80M |
| September 19, 2024 | 156.01M |
| September 18, 2024 | 145.40M |
| September 17, 2024 | 151.85M |
| September 16, 2024 | 149.97M |
| September 13, 2024 | 150.39M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
53.85M
Minimum
Dec 27 2022
2.059B
Maximum
Jun 23 2020
442.00M
Average
176.53M
Median
Market Cap Benchmarks
| EyePoint Pharmaceuticals Inc | 569.90M |
| Cassava Sciences Inc | 1.548B |
| Regenxbio Inc | 454.82M |
| Editas Medicine Inc | 195.64M |
| Apellis Pharmaceuticals Inc | 3.452B |
Market Cap Related Metrics
| Price to Book Value | 0.83 |
| Price | 5.75 |
| Earnings Yield | -104.5% |